background image

Paid Clinical Trials California

Discover 5,126 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Recruiting
PHASE1

Sponsor:

National Cancer Institute (NCI)

Location:

Palo Alto CA, Los Angeles CA, Aurora CO, Houston TXshow 8 more

Code:

NCT03598244

Conditions

Recurrent Diffuse Intrinsic Pontine Glioma

Recurrent Malignant Glioma

Recurrent Medulloblastoma

Recurrent Primary Central Nervous System Neoplasm

Refractory Diffuse Intrinsic Pontine Glioma

Eligibility Criteria

Sex: All

Age: 6 - 21

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Magnetic Resonance Imaging

Savolitinib

X-Ray Imaging

Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC)

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

La Jolla CA, Shreveport LA, Detroit MI

Code:

NCT05883644

Conditions

Advanced Hepatocellular Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Durvalumab

Tremelimumab

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

Recruiting
PHASE2

Sponsor:

Iovance Biotherapeutics, Inc.

Location:

Los Angeles CA, Oklahoma City OK, Houston TX, Louisville KYshow 3 more

Code:

NCT06481592

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Lifileucel

First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor.

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

San Francisco CA, Los Angeles CA, La Jolla CA, Tucson AZshow 14 more

Code:

NCT06603844

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-601 monoclonal antibody

Anti-PD-1 monoclonal antibody

Immune-priming single lesion SBRT

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Recruiting
PHASE1

Sponsor:

Immusoft of CA, Inc.

Location:

Oakland CA, Minneapolis MN

Code:

NCT05682144

Conditions

Mucopolysaccharidosis IH/S

Mucopolysaccharidosis IS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Autologous Plasmablasts (B cells)

A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Duarte CA, Los Angeles CA, Irvine CA, Boise IDshow 16 more

Code:

NCT06614192

Conditions

Metastatic Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-400

Trifluridine/Tipiracil

Bevacizumab

A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Recruiting
PHASE3

Sponsor:

GlaxoSmithKline

Location:

Modesto CA, Valencia CA, North Hollywood CA, Los Angeles CAshow 23 more

Code:

NCT06597344

Conditions

Urinary Tract Infections

Eligibility Criteria

Sex: Female

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Gepotidacin

Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound

Recruiting

Sponsor:

UCLA

Location:

Fresno CA

Code:

NCT03109444

Conditions

Newborn

Hip Dysplasia

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

Interventions

Hip Ultrasound

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Recruiting
PHASE2

Sponsor:

Processa Pharmaceuticals

Location:

Los Angeles CA, Tucson AZ, San Antonio TX, Austin TXshow 5 more

Code:

NCT06568692

Conditions

Breast Cancer

TNBC - Triple-Negative Breast Cancer

HER2-negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PCS6422 and capecitabine

Capecitabine

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Recruiting
PHASE2

Sponsor:

Eli Lilly and Company

Location:

Riverside CA, Irvine CA, Palm Springs CA, San Diego CAshow 45 more

Code:

NCT05986292

Conditions

Osteoarthritis, Knee

Diabetic Neuropathic Pain

Chronic Low-back Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3016859 ISA

LY3556050 ISA

LY3526318 ISA

LY3857210 ISA

Placebo Oral

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California